rheumatoid arthritis Tagged Articles

Chemotherapy drugs recalled due to glass particles in vials
Posted: July 18, 2012 Recalls

Hospira Inc. is recalling certain lots of injectable chemotherapy drugs because the vials may be contaminated with tiny particles that can be inadvertently injected into patients, which could cause serious health problems that require immediate medical intervention.

FDA panel considers benefits, risks of experimental rheumatoid arthritis drug
Posted: May 8, 2012 Pharmaceutical

Drug regulators are questioning whether an experimental drug for rheumatoid arthritis has too great of a cancer risk and whether it actually works as well as the drug company claims. The drug, tofacitinib, marketed by Pfizer, is under review by

Research suggests juvenile arthritis drug may not be cause of cancer
Posted: February 21, 2012 Pharmaceutical

University of Alabama Birmingham (UAB) pharmicoepidemiologist Tim Beukelman and his team of researchers combed through millions of records of children to determine if a life-altering drug for juvenile arthritis, called a TNF-Blocker, could cause cancer. The drugs are considered highly

DePuy artificial hip patients may be victim of faulty design
Posted: December 5, 2011 Pharmaceutical

Stephen Ellis, 57, of the United Kingdom, was furious when he learned that black liquid drained from his right hip joint during revision surgery to replace his two-year-old metal hip implant which had started poisoning his blood. Ellis suffers from

Labels on TNFa blockers get stronger warning
Posted: September 19, 2011 Product Liability

The black box warning for a class of immunosuppressant drugs known as Tumor Necrosis Factor-alpha (TNFa) blockers is being updated to include the risk of potentially deadly infections from two bacterial pathogens, Legionella and Listeria. TNFa blockers are biologic products

Painkillers, diabetes drugs among most prescribed medications
Posted: April 21, 2011 Pharmaceutical

The top 10 most prescribed drugs in America include pills to treat pain, diabetes, high cholesterol and high blood pressure, according to a report published this week by the IMS Institute for Healthcare Informatics. The best selling drug with more

Chron’s, colitis drug linked to deadly cancer
Posted: April 15, 2011 Product Liability

A fast-growing and deadly type of cancer has been reported in patients – in particular, adolescents and young adults – who are taking a type of medication used to treat Crohn’s disease and ulcerative colitis. The Food and Drug Administration

2010 an up-and-down year for arthritis sufferers
Posted: January 10, 2011 Pharmaceutical

The year 2010 has been a roller coaster ride of sorts for patients who suffer from arthritis. The year kicked off with the Food and Drug Administration (FDA) approving a new treatment for rheumatoid arthritis, and ended with the FDA

Rheumatoid arthritis drug gets new Black Box Warning
Posted: July 16, 2010 Product Liability

The Food and Drug Administration (FDA) has placed a new black box warning on Arava (leflunomide), a drug used to treat rheumatoid arthritis, because it can increase the risk of severe liver injury. The drug’s current Boxed Warning states that

New arthritis drug linked to SJS, TEN
Posted: May 3, 2010 Pharmaceutical

A newly approved drug for the treatment of arthritis in patients at risk of developing NSAID-associated gastric ulcers has been linked to a rare but serious hypersensitivity disorder known as Stevens Johnson Syndrome (SJS).